OncoCyte News

OncoCyte | 8-K: Current report

May 31 16:10 ET

OncoCyte | 8-K: Current report

May 23 16:12 ET

OncoCyte | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

May 17 17:14 ET

OncoCyte | 8-K: ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 15 22:26 ET

OncoCyte | S-3: Registration statement for specified transactions by certain issuers

May 10 17:34 ET

OncoCyte | DEF 14A: Definitive information statements

Apr 29 17:25 ET

OncoCyte | 8-K: Current report

Apr 12 06:07 ET

OncoCyte | 8-K: Current report

Apr 11 17:33 ET

OncoCyte | NT 10-K: Others

Apr 1 17:08 ET

OncoCyte | 8-K: Current report

Jan 23 00:00 ET

OncoCyte | 8-K: ONCOCYTE REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS -Launching First Products in 1H 2024- -Conference Call on Thursday, November 9, 2023 at 5:00 a.m. PT / 8:00 a.m. ET-

Nov 9, 2023 07:05 ET

OncoCyte | 8-K/A: Current report (Amendment)

Oct 10, 2023 16:48 ET

OncoCyte | 8-K: Current report

Oct 5, 2023 16:05 ET

OncoCyte | 8-K: Current report

Sep 20, 2023 09:00 ET

OncoCyte | 8-K: Current report

Aug 28, 2023 16:05 ET

OncoCyte | 8-K: ONCOCYTE REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS Conference Call on Thursday, August 10, 2023 at 5:00 a.m. PT / 8:00 a.m. ET

Aug 10, 2023 07:05 ET

OncoCyte | 8-K: Current report

Jul 24, 2023 17:28 ET

OncoCyte | DEFA14A: Others

Jul 21, 2023 17:16 ET

OncoCyte | 8-K: Current report

Jul 14, 2023 06:03 ET

OncoCyte | DEF 14A: Definitive information statements

Jul 10, 2023 11:20 ET